Session Information

WCLC 2017

18th World Conference on Lung Cancer

Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan

Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.
Presentation Date(s):
- Oct 15 - 18, 2017
- Total Presentations: 2295
Register to Attend WCLC Return to WCLC 2017 Website Switch to Virtual Meeting
Enter Virtual Meeting Access Code

All Days Saturday
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18

Filter Results:

Show Only CME Accredited Sessions

20203

+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
- 22448
  
  +
  
  P1.01-042 - Dynamic ctDNA Assay by Next Generation Sequencing to Guide Targeted Therapy in Advanced Non-Small Cell Lung Cancer
  
  09:30 - 09:30 | Presenter: Xiaochun Zhang | Author(s): D. Liu, H. Hou, N. Zhou, Man Jiang, J. Cong, C. Zhang, T. Li, H. Lv, J. Zhu, C. Hao, K. Liu
  Abstract
  
  Loading...
- 22475
  
  +
  
  P1.01-069 - Clinical Experience with IBM Watson for Oncology (WFO) Cognitive System for Lung Cancer Treatment in China
  
  09:30 - 09:30 | Presenter: Xiaochun Zhang | Author(s): N. Zhou, H. Lv, C. Zhang, T. Li, J. Zhu, Man Jiang, H. Hou, D. Liu, A. Li, G. Liu, K. Liu, G. Zhang
  Abstract
  
  Loading...
20152

+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
- 22563
  
  +
  
  P1.03-008 - Analysis of Data on Interstitial Lung Disease Onset and Its Risk Following Treatment of ALK-positive NSCLC with Xalkori
  
  09:30 - 09:30 | Presenter: Akihiko Gemma | Author(s): Masahiko Kusumoto, Y. Kurihara, N. Masuda, S. Banno, Y. Endo, H. Houzawa, N. Ueno, E. Ohki, A. Yoshimura
  Abstract
  
  Loading...
20161

+
P1.12 - Pulmonology/Endoscopy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Pulmonology/Endoscopy
- 22753
  
  +
  
  P1.12-006 - The Efficacy of Electrocautery Using Wire Snare as the Primary Ablation Modality for Malignant and Benign Airway Obstruction
  
  09:30 - 09:30 | Presenter: Masahiko Harada | Author(s): T. Hishima, T. Yamamichi, A. Asakawa, M. Okui, H. Horio
  Abstract
  
  Loading...
20167

+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
- 23305
  
  +
  
  P2.03-034 - EGFR Exon 19 Deletion Is Associated with Favorable Overall Survival After First-Line Icotinib Therapy in Advanced NSCLC Patients
  
  09:30 - 09:30 | Presenter: Xiaochun Zhang | Author(s): C. Zhang, H. Hou, X. Cheng, D. Gong, H. Liu, H. Yu, W. Zhu, J. Zhu, K. Liu, H. Lv, N. Zhou, J. Cong, D. Liu, L. Yang, M. Jiang, Y. Zhang, L. Chen, Y. Zhu
  Abstract
  
  Loading...
20129

+
MA 12 - Circumventing EGFR Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Wan Ling Tan, Nobuyuki Yamamoto
- 23623
  
  +
  
  MA 12.01 - A Phase Ib Study of the Combination of Afatinib and Ruxolitinib in EGFR Mutant NSCLC Progressed on EGFR-TKI: An Updated Analysis
  
  11:00 - 11:05 | Presenter: Ji Soo Park | Author(s): M.H. Hong, Byoung Chul Cho, Hye Ryun Kim
  Abstract
  
  Loading...
18974

+
P3.02 - Biology/Pathology
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
- 23992
  
  +
  
  P3.02-044 - Diagnosis and Monitoring of EGFR Mutation Status with cfDNA in Advanced NSCLC: A Prospective Single Institution Study in Asia
  
  09:30 - 09:30 | Presenter: Teh-Ying Chou | Author(s): H. Ho, C. Chiu, C. Tsai, P.M. Das
  Abstract
  
  Loading...
20182

+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
- 24063
  
  +
  
  P3.03-018 - Tumor Cavitation in Lung Metastases in Patients with Solid Tumor Treated with Apatinib
  
  09:30 - 09:30 | Presenter: Man Jiang | Author(s): N. Zhou, D. Liu, H. Hou, J. Cong, C. Zhang, Xiaochun Zhang
  Abstract
  
  Loading...
20184

+
P3.05 - Early Stage NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Early Stage NSCLC
- 24595
  
  +
  
  P3.05-012a - Inference of Gene Expressions Associated with Recurrence of Non-Small Cell Lung Cancer
  
  09:30 - 09:30 | Presenter: Seo Ree Kim | Author(s): J.H. Lee, J.H. Hong
  Abstract
  
  Loading...
20193

+
P3.14 - Radiotherapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
- 24191
  
  +
  
  P3.14-001 - Impact of PCI on Prognosis of LD-SCLC Through Pattern of Brain Metastases as a First Recurrence Site
  
  09:30 - 09:30 | Presenter: Masaki Nakamura | Author(s): M. Onozawa, A. Motegi, H. Hojo, S. Zenda, N. Nakamura, H. Udagawa, K. Kirita, S. Matsumoto, S. Umemura, K. Yoh, Seiji Niho, Koichi Goto, T. Akimoto
  Abstract
  
  Loading...

Session Information

WCLC 2017

18th World Conference on Lung Cancer

Enter Virtual Meeting Access Code

+

P1.01 - Advanced NSCLC

+

P1.01-042 - Dynamic ctDNA Assay by Next Generation Sequencing to Guide Targeted Therapy in Advanced Non-Small Cell Lung Cancer

+

P1.01-069 - Clinical Experience with IBM Watson for Oncology (WFO) Cognitive System for Lung Cancer Treatment in China

+

P1.03 - Chemotherapy/Targeted Therapy

+

P1.03-008 - Analysis of Data on Interstitial Lung Disease Onset and Its Risk Following Treatment of ALK-positive NSCLC with Xalkori

+

P1.12 - Pulmonology/Endoscopy

+

P1.12-006 - The Efficacy of Electrocautery Using Wire Snare as the Primary Ablation Modality for Malignant and Benign Airway Obstruction

+

P2.03 - Chemotherapy/Targeted Therapy

+

P2.03-034 - EGFR Exon 19 Deletion Is Associated with Favorable Overall Survival After First-Line Icotinib Therapy in Advanced NSCLC Patients

+

MA 12 - Circumventing EGFR Resistance

+

MA 12.01 - A Phase Ib Study of the Combination of Afatinib and Ruxolitinib in EGFR Mutant NSCLC Progressed on EGFR-TKI: An Updated Analysis

+

P3.02 - Biology/Pathology

+

P3.02-044 - Diagnosis and Monitoring of EGFR Mutation Status with cfDNA in Advanced NSCLC: A Prospective Single Institution Study in Asia

+

P3.03 - Chemotherapy/Targeted Therapy

+

P3.03-018 - Tumor Cavitation in Lung Metastases in Patients with Solid Tumor Treated with Apatinib

+

P3.05 - Early Stage NSCLC

+

P3.05-012a - Inference of Gene Expressions Associated with Recurrence of Non-Small Cell Lung Cancer

+

P3.14 - Radiotherapy

+

P3.14-001 - Impact of PCI on Prognosis of LD-SCLC Through Pattern of Brain Metastases as a First Recurrence Site

Stay Connected